Sort   by:  
 Page size 
ProteomicsHigh throughput microfluidic 3D biomimetic model enabling quantitative description of human breast tumor microenvironment
Cancer is driven by genetic aberrations in the tumor cells and fundamental changes in the tumor microenvironment (TME). These changes offer potential targets for novel therapeutics, yet lack of in vitro 3D models recapitulating this complex microenvironment impedes such progress. Here, we generated ...
ORGANISM(S): Homo sapiens (Human) 
2022-10-13 | PXD021509 | Pride
Breast cancer Microfluidics Tumor microenvironment Proteomic profiling Alginate 
TranscriptomicsmRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer
The intention was to detect genes that are determining trastuzumab efficiency in HER2-positive breast cancer cell lines with different resistance phenotypes. While BT474 should be sensitive to the drug treatment, HCC1954 is expected to be resistant due to a PI3K mutation. The cell line BTR50 has bee...
ORGANISM(S): Homo sapiens 
2015-04-21 | E-GEOD-55005 | biostudies-arrayexpress
ProteomicsCE-MS Top Down Proteomics Multi-lab Study
A single gene can give rise to multiple functionally distinct forms of protein molecules, called proteoforms, originating from gene mutations, RNA alternative splicing, polymorphisms, and post-translational modifications (PTMs). It is essential to characterize proteins in a proteoform-specific manne...
ORGANISM(S): Saccharomyces cerevisiae (Baker's yeast) 
2025-12-18 | PXD059108 | Pride
Ce-ms Top down proteomics Ce Ms 
UnknownHigh rate of bacterial respiratory tract co-infections upon admission amongst moderate to severe COVID-19 patients.
Not available
S-EPMC8500304 | biostudies-literature
UnknownAge, Motion, Medical, and Psychiatric Associations With Incidental Findings in Brain MRI.
Not available
S-EPMC10865144 | biostudies-literature
ProteomicsProteomic and Metabolomic Characterization of COVID-19 Patient Sera MRMHR
Targeted mass spectrometric assays for the 22 proteins in a second test cohort containing 19 COVID-19 patients
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2020-05-30 | MSV000085515 | MassIVE
ProteomicsProteomic and Metabolomic Characterization of COVID-19 Patient Sera
Early detection and effective treatment of severe COVID-19 patients remain major challenges. Here, we performed proteomic and metabolomic profiling of sera from 46 COVID-19 and 53 control individuals. We then trained a machine learning model using proteomic and metabolomic measurements from a traini...
ORGANISM(S): Severe Acute Respiratory Syndrome Coronavirus 2 (ncbitaxon:2697049) Homo Sapiens (ncbitaxon:9606) 
2020-05-29 | MSV000085507 | MassIVE
UnknownBaseline procalcitonin as a predictor of bacterial infection and clinical outcomes in COVID-19: A case-control study.
Not available
S-EPMC8758006 | biostudies-literature
UnknownKidney function and other factors and their association with falls : The screening for CKD among older people across Europe (SCOPE) study.
Not available
S-EPMC7531089 | biostudies-literature
UnknownEffects of Renal Denervation vs Sham in Resistant Hypertension After Medication Escalation: Prespecified Analysis at 6 Months of the RADIANCE-HTN TRIO Randomized Clinical Trial.
Not available
S-EPMC9647563 | biostudies-literature
Sort   by:  
 Page size